Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease prostate cancer
Symptom C0002871|anaemia
Sentences 3
PubMedID- 23984103 Studies have shown that s.c. administration of recombinant human erythropoietin (150 u/kg three times weekly) is an effective treatment for managing poorly tolerated anaemia in men with androgen-independent prostate cancer, achieving a greater than 10% increase in haemoglobin concentrations .
PubMedID- 19863346 Erythropoiesis pathology and causes of anaemia in prostate cancer are reviewed.
PubMedID- 20540802 anaemia and thrombocytopenia in patients with prostate cancer and bone metastases.

Page: 1